{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:10:51Z","timestamp":1793052651075,"version":"4.5.0"},"reference-count":40,"publisher":"BMJ","issue":"2","funder":[{"name":"Bill Siganto","award":["Bill Siganto Award"],"award-info":[{"award-number":["Bill Siganto Award"]}]},{"DOI":"10.13039\/100015471","name":"Mater Foundation","doi-asserted-by":"crossref","award":["Clinical Research Seeding Grant"],"award-info":[{"award-number":["Clinical Research Seeding Grant"]}],"id":[{"id":"10.13039\/100015471","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2025,12,2]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Men with castrate-resistant prostate cancer (CRPC) suffer from symptoms related to both their disease and its treatment with marked variation between individuals with respect to symptom expression. This study aimed to determine whether genetic variation in cytokine expression is associated with symptom severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An exploratory prospective, longitudinal consecutive patient cohort study was undertaken across two Queensland sites. Patient characteristics including tumour burden and current treatment were collected at baseline. Symptom severity was assessed 3\u20134 weekly for up to 6 assessments, with blood taken for genetic analysis once only during the study. Cytokine gene variants of each participant were assessed using a panel of single nucleotide polymorphisms (SNPs) most described in the literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 66 participants, 27\/66 (41%) had a low, and 39\/66 (59%) a high tumour burden. Symptom severity was not related to tumour burden or patient characteristics. Of the 142 SNPs analysed from 62 participants, 15 SNPs from 7 genes were significantly associated with symptom severity. After Benjamini-Hochberg adjustment, SNPs rs2069772 from Interleukin-2 (IL2) and rs230494 from Nuclear Factor kappa-light-chain-enhancer of activated B cells (NFKb) remained significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although multiple factors can influence symptom severity, genetic variation may play a part. The early identification of men likely to develop severe symptoms during the course of their prostate cancer could theoretically enable symptoms to be managed more aggressively from an early stage. These preliminary findings need to be replicated in a larger cohort of men with CRPC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/spcare-2025-005510","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T18:20:25Z","timestamp":1766082025000},"page":"393-400","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Genomic variation in symptom expression in castrate-resistant prostate cancer"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1127-9951","authenticated-orcid":false,"given":"Janet","family":"Hardy","sequence":"first","affiliation":[{"name":"Mater Research Institute The University of Queensland, South Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1574-4729","authenticated-orcid":false,"given":"Ristan","family":"Greer","sequence":"additional","affiliation":[{"name":"Mater Research Institute The University of Queensland, South Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7525-1547","authenticated-orcid":false,"given":"Karyn","family":"Foster","sequence":"additional","affiliation":[{"name":"Mater Research Institute The University of Queensland, South Brisbane, Queensland, Australia"},{"name":"Department of Palliative and Supportive Care, Mater Misericordiae Ltd, South Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7103-2200","authenticated-orcid":false,"given":"Niara","family":"Oliveira","sequence":"additional","affiliation":[{"name":"The University of Queensland Mater Clinical Unit, South Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8198-0375","authenticated-orcid":false,"given":"Phillip","family":"Good","sequence":"additional","affiliation":[{"name":"Mater Research Institute The University of Queensland, South Brisbane, Queensland, Australia"},{"name":"Department of Palliative and Supportive Care, Mater Misericordiae Ltd, South Brisbane, Queensland, Australia"},{"name":"Supportive and Palliative Care, St Vincent\u2019s Private Hospital Brisbane, Kangaroo Point, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4642-4290","authenticated-orcid":false,"given":"Petra","family":"Vayne-Bossert","sequence":"additional","affiliation":[{"name":"Geneva University Hospitals, Geneva, GE, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D","family":"Ewing","sequence":"additional","affiliation":[{"name":"Mater Research Institute The University of Queensland, South Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"2026022702201306000_16.2.393.1","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27175730","article-title":"Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"key":"2026022702201306000_16.2.393.2","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1200\/JCO.20.03256","article-title":"Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update","volume":"39","author":"Virgo","year":"2021","journal-title":"J Clin Oncol"},{"key":"2026022702201306000_16.2.393.3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ucl.2012.07.006","article-title":"Palliative care in castrate-resistant prostate cancer","volume":"39","author":"Rabow","year":"2012","journal-title":"Urol Clin North Am"},{"key":"2026022702201306000_16.2.393.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-013-1751-5"},{"key":"2026022702201306000_16.2.393.5","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2011.0219"},{"key":"2026022702201306000_16.2.393.6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12904-024-01410-w","article-title":"Symptoms and quality of life among men starting treatment for metastatic castration-resistant prostate cancer - a prospective multicenter study","volume":"23","author":"R\u00f6nning\u00e5s","year":"2024","journal-title":"BMC Palliat Care"},{"key":"2026022702201306000_16.2.393.7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/IJPC.IJPC_135_16","article-title":"Assessment of Cancer-related Fatigue among Cancer Patients Receiving Various Therapies: A Cross-sectional Observational Study","volume":"23","author":"Banipal","year":"2017","journal-title":"Indian J Palliat Care"},{"key":"2026022702201306000_16.2.393.8","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1007\/s11136-019-02212-x","article-title":"Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy","volume":"28","author":"Wilding","year":"2019","journal-title":"Qual Life Res"},{"key":"2026022702201306000_16.2.393.9","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgh023"},{"key":"2026022702201306000_16.2.393.10","doi-asserted-by":"publisher","DOI":"10.1378\/chest.117.4.1162"},{"key":"2026022702201306000_16.2.393.11","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-10-0994"},{"key":"2026022702201306000_16.2.393.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2012.02.015"},{"key":"2026022702201306000_16.2.393.13","first-page":"3117","article-title":"Symptom clusters of pain, depressed mood, and fatigue in lung cancer: assessing the role of cytokine genes","volume":"21","author":"Reyes-Gibby","year":"2013","journal-title":"Support Care Cancer"},{"key":"2026022702201306000_16.2.393.14","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/cncr.29154","article-title":"Racial\/ethnic disparities in inflammatory gene single-nucleotide polymorphisms as predictors of a high risk for symptom burden in patients with multiple myeloma 1 year after diagnosis","volume":"121","author":"Shi","year":"2015","journal-title":"Cancer"},{"key":"2026022702201306000_16.2.393.15","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25255"},{"key":"2026022702201306000_16.2.393.16","doi-asserted-by":"crossref","unstructured":"Bayer SJ , Yang GS , Lyon DE . Genetic variation associated with depressive symptoms in breast cancer patients: a systematic review. Cancer Nurs 2022;E197\u2013205. doi:10.1002\/cncr.25255","DOI":"10.1097\/NCC.0000000000000903"},{"key":"2026022702201306000_16.2.393.17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040560","article-title":"Evidence of associations between cytokine genes and subjective reports of sleep disturbance in oncology patients and their family caregivers","volume":"7","author":"Miaskowski","year":"2012","journal-title":"PLoS One"},{"key":"2026022702201306000_16.2.393.18","first-page":"100189","article-title":"Genetic associations of fatigue and other symptoms following breast cancer treatment: A prospective study","volume":"10","author":"Cameron","year":"2021","journal-title":"BBI Health"},{"key":"2026022702201306000_16.2.393.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503747"},{"key":"2026022702201306000_16.2.393.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2014.10.013"},{"key":"2026022702201306000_16.2.393.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2012.11.009"},{"key":"2026022702201306000_16.2.393.22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093392","article-title":"A high throughput single nucleotide polymorphism multiplex assay for parentage assignment in New Zealand sheep","volume":"9","author":"Clarke","year":"2014","journal-title":"PLoS ONE"},{"key":"2026022702201306000_16.2.393.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(01)00297-2"},{"key":"2026022702201306000_16.2.393.24","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btl675"},{"key":"2026022702201306000_16.2.393.25","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jpainsymman.2017.07.045","article-title":"Symptom Clusters in Men With Castrate-Resistant Prostate Cancer","volume":"54","author":"Vayne-Bossert","year":"2017","journal-title":"J Pain Symptom Manage"},{"key":"2026022702201306000_16.2.393.26","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-008-0592-7"},{"key":"2026022702201306000_16.2.393.27","unstructured":"Available: https:\/\/gtexportal.org\/home\/snp\/rs230494"},{"key":"2026022702201306000_16.2.393.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.08.030"},{"key":"2026022702201306000_16.2.393.29","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2507"},{"key":"2026022702201306000_16.2.393.30","doi-asserted-by":"publisher","DOI":"10.1177\/1099800414550394"},{"key":"2026022702201306000_16.2.393.31","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.2147\/OTT.S103159","article-title":"Association of polymorphisms in interleukin-8 gene with cancer risk: a meta-analysis of 22 case-control studies","volume":"9","author":"Zhang","year":"2016","journal-title":"Onco Targets Ther"},{"key":"2026022702201306000_16.2.393.32","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4843"},{"key":"2026022702201306000_16.2.393.33","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-19-0595"},{"key":"2026022702201306000_16.2.393.34","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-320441"},{"key":"2026022702201306000_16.2.393.35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","article-title":"Roles of IFN-\u03b3 in tumor progression and regression: a review","volume":"8","author":"Jorgovanovic","year":"2020","journal-title":"Biomark Res"},{"key":"2026022702201306000_16.2.393.36","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.26.021607.090357"},{"key":"2026022702201306000_16.2.393.37","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1159\/000464381","article-title":"Interleukin-2 and Interleukin-8 Gene Polymorphisms and Acquired Aplastic Anemia Risk in a Chinese Population","volume":"41","author":"Zhang","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"2026022702201306000_16.2.393.38","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-09-0426"},{"key":"2026022702201306000_16.2.393.39","doi-asserted-by":"publisher","DOI":"10.1111\/febs.13627"},{"key":"2026022702201306000_16.2.393.40","doi-asserted-by":"crossref","first-page":"151652","DOI":"10.1016\/j.soncn.2024.151652","article-title":"Chronic Decrements in Energy in Women with Breast Cancer are Associated with Cytokine Gene Polymorphisms","volume":"40","author":"Miaskowski","year":"2024","journal-title":"Semin Oncol Nurs"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2025-005510","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T10:21:51Z","timestamp":1772187711000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2025-005510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,27]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/spcare-2025-005510"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2025-005510","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]}}}